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Summary Differentiation-inducing ability of y-radiation, N,N-dimethylformamide and their combination has
been tested on human rhabdomyosarcoma RMZ-RC2 clone cells. Ionising radiation at 2-5 Gy doses induced a
more differentiated morphology, with the appearance of an increased proportion of multinuclear myotube-like
cells, and a significant increase in myosin-positive and multinuclear cells. Radiation appeared to act by
inducing de novo differentiated elements. N,N-dimethylformamide was able to induce an increased myosin
expression, but did not affect multinuclear cell proportion. The combined treatment (ionising radiation and
N,N-dimethylformamide) resulted in an additive increase in the proportion of myosin-positive cells, ap-
proaching 25-35%, but de novo differentiated elements were not increased above the levels obtained with
irradiation alone.
Differentiation induction therapy has been mainly investi-
gated in leukaemic cells and in rodent solid tumours. In the
last decade a few suitable human model systems have been
developed (Reiss et al., 1986; Waxman et al., 1988).
Induction of differentiation has been recently studied in
human rhabdomyosarcoma cells. In vitro treatment with
retinoic acid (Garvin et al., 1986) and phorbol esters
(Aguanno et al., 1990) can induce myogenic differentiation;
moreover in vivo growth and metastasisation in nude mice
were impaired by differentiation induction (Lollini et al.,
1991). We have previously shown that also some (but not all)
antineoplastic drugs can induce myogenic differentiation of
human rhabdomyosarcoma cells (Lollini et al., 1989). How-
ever in our model system, as in other solid tumours, a
complete differentiation was not obtained; the possibility that
combined differentiation therapy regimens might be more
effective is now being investigated (Wiemann et al., 1988).
In rodent rhabdomyosarcoma models, differentiation could
be induced also by different polar compounds, e.g. N,N-
dimethylformamide (Dexter, 1977) and N-methylformamide
(Gerharz et al., 1989). Moreover, these compounds have been
reported to enhance radiosensitivity of some human tumour
cell cultures (Leith et al., 1982; Leith et al., 1985; Arundel et
al., 1987).
The aims of the present work are (a) to analyse the effect
in vitro of a common therapeutic approach, radiation
therapy, on the differentiation of human rhabdomyosarcoma
cells, which are known to be radiosensitive (Kelland et al.,
1989), and (b) to assess whether the combination of ionising
radiation with an inducer of differentiation, N,N-dimethyl-
formamide, may lead to an enhancement of myogenic differ-
entiation.
Materials and methods
Cells andstandard culture conditions
Clone RMZ-RC2, derived from a human alveolar rhabdo-
myosarcoma and previously characterised (Nanni et al.,
1986), was used between the 20th and the 30th in vitro
passages. Cells were routinely maintained in Dulbecco's
modified Eagle medium supplemented with 100 U ml-I penicil-
lin, 100i,gml-' streptomycin (hereafter referred to as
DMEM) and with 10% foetal calf serum (FCS). All media
constituents were purchased from GIBCO, Paisley, Scotland.
Cell cultures were incubated at 37°C in a humidified 5% CO2
atmosphere. Cells were monitored for mycoplasma con-
tamination by fluorescent staining with Hoechst 33258
(Chen, 1977) and found to be mycoplasma-free.
Induction ofdifferentiation
Cells were seeded on day 0 into T25 flasks (Falcon Plastics,
Oxnard, USA) at 30,000 cells cm-2 in standard growth
medium; after 24 h (day 1) cells were treated with different
doses (0-10 Gy) of radiations ('Co, 4.2 Gy min '); on day
4 both irradiated and control cultures were switched to
DMEM + 1% FCS, which was subsequently renewed every
second day.
N,N-dimethylformamide (DMF) (Fluka Chemie AG,
Buchs, Switzerland) was added on day 7 to cells seeded and
cultured as above; cells were maintained in the presence of
DMF until the end of experiment. In preliminary
experiments, two concentrations of DMF (0.5% and 1%)
were tested. A dose-dependent decrease in cell yield was
observed (respectively, about 80% and 20% with respect to
control yield); both doses induced a similar increase in the
proportion of myosin-positive cells (control: 12%; 0.5%
DMF: 22%; 1% DMF: 26%). In order to combine DMF
treatment with irradiation (that strongly decreases cell yield),
the 0.5% dose was chosen for all the subsequent experiments.
Combined differentiation induction was evaluated in cul-
tures irradiated on day 1 and subjected to DMF from day 7
onwards.
Evaluation ofdiferentiation
Cells were harvested on day 1, 7 and 11, counted and centri-
fuged at 400 g for 10min onto glass slides. Cytocentrifuge
slides were immediately fixed with methanol:acetone (3:7) at
- 20°C and stained as described (Nanni et al., 1986) in an
indirect immunofluorescence assay with BF-G6 monoclonal
antibody recognising embryonic myosin (Schiaffino et al.,
1986). After washing off the unbound fluorescein-conjugated
second antibody (Technogenetics, Milano, Italy), cell nuclei
were stained with ethidium bromide (100 gg ml-' in
phosphate-buffered saline) for 5 min. After extensive
washings and mounting, slides were examined under a
Reichert Biovar microscope equipped for phase contrast and
green-red fluorescence. At least 300 cell elements (either
mono- or multinuclear) in random fields were scored at
312.5 x for determining the percentage of myosin-positive
cells. At least 200 nuclei in random fields were scored at
1250 x for the simultaneous determination of the number of
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nuclei per cell and of myosin positivity.
From cell yield per culture flask and percentage of myosin-
positive cells we determined the absolute number of myosin-
positive cells per culture flask. The percentage of de novo
differentiation (Lollini et al., 1989) was calculated as:
100 x (Number of myosin-positive cells at day 11
- Number of myosin-positive cells at day x)/Total number
of cells at day 11,
where 'day x' corresponds to the day in which treatment
started.
Since RMZ-RC2 cells form myotube-like elements (ter-
minally differentiated multinuclear myosin-positive cells), we
calculated also de novo differentiation of myotube-like cells
as:
100 x (Number of multinuclear myosin-positive cells at
day 11 - Number of multinuclear myosin-positive cells at
day x)/Total number of cells at day 11.
Results
Induction ofdifferentiation by y-radiation
Human alveolar rhabdomyosarcoma RMZ-RC2 clone cells
were treated in vitro with 'Co y-rays 24 h after seeding.
Myogenic differentiation was evaluated after 7 and 11 days
of culture by means of the determination of percentage of
myosin-positive cells on cytocentrifuge slides, somatic fusion
and formation of multinuclear cells.
Preliminary experiments with radiation doses up to 10 Gy
revealed that y-irradiation induced an increase in the percent-
age of myosin-positive cells. A plateau level was obtained
with doses in excess of 5 Gy. Therefore in this study RMZ-
RC2 cells were subjected to 1-5 Gy. The effects of these doses
on cell survival are reported in Table I.
A significant dose-related increase in myosin expression
was observed in RMZ-RC2 cells treated with 2-5 Gy (Figure
1). Induction of differentiation was also evident morpho-
logically, with the appearance of an increased proportion of
multinuclear myotube-like cells (Figure 2). The percentage of
multinuclear myosin-positive cells was also increased (Figure
3).
Since a small proportion of myosin-positive and terminally-
differentiated postmitotic cells is always present in RMZ-
RC2 cultures (Lollini et al., 1989), we examined the
possibility that the positive effects on differentiation could in
some cases be due to a negative selection of proliferating
cells. In particular we have shown that some substances can
cause an increase in the proportion of differentiated elements
through a strong reduction in the number ofnon-differentiated
cells, in the presence of a constant number of differentiated
elements. We proposed a parameter called 'de novo
differentiation' (Lollini et al., 1989) which evaluates both
differentiation-inducing and toxic effects of treatment.
Irradiation was able to induce a percentage of de novo
differentiation higher than that observed in untreated cultures
(Figure 4), thus indicating that the increase in myosin-
positive cells (see Figure 1) and in multinuclear myotube-like
cells (see Figure 3) was indeed mediated by the induction of
myogenic differentiation. It can be noted that the highest
percentage ofmyosin-positive cells did not always correspond
to the highest de novo differentiation: the latter showed a
peak around 3 Gy, a dose that did not induce a severe
reduction in cell survival. At very toxic doses, a decrease in
de novo differentiation was observed. When de novo
differentiation of multinuclear myosin-positive cells was con-
sidered, maximal effect was observed at 4 Gy dose.
N,N-dimethylformamide treatment
Cell treatment with 0.5% N,N-dimethylformamide induced
an increased percentage ofmyosin-positive cells (20.1 ± 1.6 vs
12.5 ± 0.9). No significant variation in multinuclear cell for-
mation was observed. De novo differentiation of myosin-
positive cells, calculated vs parameters of day 7 (i.e. when
Table I Effect ofy-irradiation on in vitro cell growth of RMZ-RC2
cells
Radiation dose Cell yield (% of control)
(Gy) 7 days 11 days
0 100 100
1 82± 2 89 11
2 60 12 71 15
3 30± 4 29± 8
4 19± 4 12± 3
5 11± 2 5± 1
Data are expressed as mean ± standard error of four experiments.
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Figure 1 Effect of y-irradiation with different doses (0-5 Gy) on
the percentage of myosin-positive cells in rhabdomyosarcoma
RMZ-RC2 cells. Doses >2Gy induced a significant (P <0.05 at
least, Student's t-test) increase over control. Each point represents
the mean ± s.e.m. of four experiments.
treatment started), also showed a significant increase in cul-
tures treated with N,N-dimethylformamide (12.7 ± 2.0 vs
6.4 ± 1.4).
Combined treatment
The possibility that a combined treatment with y-irradiation
plus N,N-dimethylformamide could result in an enhanced
differentiation-inducing effect was tested on 11-day cultures,
in which the maximal induction of differentiation by single
treatment was previously observed. The combined treatment
resulted in an additional 50% increase in myosin expression.
However neither multinuclear cells nor de novo differentiation
were further increased above the levels obtained with
y-irradiation alone (data not shown).
Discussion
We have shown here that ionising radiation shares with some
antineoplastic drugs (Lollini et al., 1989) the ability to induce
myogenic differentiation of human rhabdomyosarcoma cells.
The treatment of RMZ-RC2 cells with radiation doses
between 2 and SGy resulted in a stimulation of cell
differentiation, as shown by morphology and quantitative
evaluation of myosin-positive cells and of myogenic cell
fusion. These data are in agreement with X-irradiation-
induced differentiation obtained in nude mice transplanted
with human rhabdomyosarcoma (Takizawa et al., 1989).
Furthermore our in vitro model system allows to exclude,
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Figure 2 Effect of v-irradiation on morphology of rhabdo-
myosarcoma RMZ-RC2 cells after 11 days of culture: a, control;
b, 3 Gy. Phase contrast, x 100.
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Figure 3 Effect of y-irradiation with different doses (0-5 Gy) on
multinuclear cells (open bars) and on myosin-positive multi-
nuclear cells (closed bars) in rhabdomyosarcoma RMZ-RC2 cells
after 11 days of culture. Doses > 3 Gy for multinuclear cells and
> 2 Gy for myosin-positive cells induced a significant (P <0.05
at least, Student's t-test) increase over control. Each bar
represents the mean ± s.e.m. of four experiments.
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Figure 4 Induction of de novo differentiation by y-irradiation on
RMZ-RC2 cells after 11 days of culture (see Materials and
methods for formulae). Significance vs non-irradiated cells
(Student's t-test): *,P <0.05; **,P <0.01.
through the determination of the absolute number of
differentiated cells and of the 'de novo differentiation'
parameter, the possibility that positive effects on differentiation
might be due solely to a negative selection of proliferating
cells.
Different polar compounds have been reported to induce
differentiation in rodent rhabdomyosarcoma cells (Dexter et
al., 1977; Gerharz et al., 1989). In our human model, N,N-
dimethylformamide increased the proportion of myosin-
positive cells, but no significant variation was observed in the
percentage of multinuclear cells, suggesting a mode of
induction different from that of y-irradiation. N-
monomethylformamide treatment has been reported to
enhance radiosensitivity of some human tumour cell cultures
(Arundel et al., 1987) and a therapeutic gain was achieved in
mice bearing a fibrosarcoma through the combination of
NMF and ionising radiation (Iwakawa et al., 1987).
The differentiation-inducing ability of y-irradiation and
N,N-dimethylformamide does not seem to be restricted to the
rhabdomyosarcoma model studied: an accelerated appearance
of myosin-positive cells was induced in CCA cell line (De
Giovanni et al., 1990) derived from an embryonal rhabdo-
myosarcoma (data not shown).
The combined treatment (irradiation plus N,N-
dimethylformamide) resulted, in our model, in an additive
effect on the proportion of myosin-positive rhabdomyosar-
coma cells. No increase in de novo differentiation was
observed, thus suggesting that either the toxic effects caused
by the combined treatment prevented the assessment of the
effects on differentiation, or a critical step in the pathway to
myogenic differentiation reached a plateau after either treat-
ment.
The proportion of myosin-positive elements attained after
treatment with ionising radiation or with N,N-dimethyl-
formamide was in the range 25-35%, thus it involved only a
minority of cells. Analogous results were obtained also with
different substances (Lollini et al., 1989). It should be noted
however that this plateau does not seem to prevent the
feasibility of differentiation therapy, since in cultures contain-
ing more than 30-40% of differentiated elements we observed
a lack of increase in total population cell number, suggesting
that the induction of such a proportion of differentiated cells
could be enough to significantly alter cell growth.
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